The Fort Worth Press

Death toll from Indonesia landslides rises to 18

The death toll from three landslides that hit Indonesia's Java island since last week has risen to 18, with more than 30 people missing, a disaster official said on Monday.

Bangladesh ex-PM sentenced to death for crimes against humanity

A Bangladesh court on Monday sentenced ousted prime minister Sheikh Hasina to death for crimes against humanity, with cheers breaking out in the packed court as the judge read out the verdict.

Singapore jails 'attention seeking' Australian over Ariana Grande incident

A Singapore court sentenced an Australian man to nine days in jail on Monday for rushing film star Ariana Grande at the Asian premiere of "Wicked: For Good" last week.

Bangladesh verdict due in ex-PM's crimes against humanity trial

Bangladeshi judges will deliver their verdict on Monday in the crimes against humanity trial of fugitive former prime minister Sheikh Hasina, a highly anticipated ruling before the first polls since her overthrow.

Avrio Announces the Appointment of James O'Neill as Chief Investment Officer to Lead Global Investment and Capital Markets Strategy

NEW YORK, NY, LONDON, UK, and ABU DHABI, UAE /ACCESS Newswire / November 17, 2025 / Avrio Worldwide PBC ("Avrio"), a global financial services technology company providing institutional-grade market infrastructure, services, and data across public, private, and digital markets, today announced the appointment of James O'Neill as Chief Investment Officer (CIO).

NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position

SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ending September 30, 2025 with the Securities and Exchange Commission (SEC) on Friday, November 14, 2025. The report can be accessed at the SEC website (https://www.sec.gov/Archives/edgar/data/1379006/000110465925112608/nnvc-20250930x10q.htm).

Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue

Initial results of ongoing investigator-initiated proof-of-concept trial demonstrate crofelemer can potentially extend the lives of infants born with intestinal failure due to microvillus inclusion disease (MVID), reducing the volume of the total parenteral support (PS) necessary for them to survive, though with associated toxicity; Groundbreaking PS reduction of up to 37%; No approved treatments exist for MVIDCompany completed meeting with FDA October 2, 2025 for advice on possible expedited approval pathway to advance its ongoing placebo-controlled trial of crofelemer for potential approval for treatment of MVIDREMINDER: Today Jaguar to host investor webcast at 8:30 a.m. Eastern regarding Q3 2025 financials and company updates; Click here to register

Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

SKNJCT-003 Doxorubicin containing Microneedle Array (D-MNA) clinical development program to non-invasively treat BCC aligns with national priorities of public health impact, unmet medical need, access, affordability, domestic manufacturing and rare-disease alignment.

Organto Foods Inc. Announces Prepayment of Convertible Notes

Optimizes Capital Structure and Financial Flexibility

OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma

OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer.

Wellgistics Health to Report Third Quarter 2025 Financial Results and Provide a Business Update on the morning of Thursday, November 20th, 2025

TAMPA, FL / ACCESS Newswire / November 17, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader at the nexus of the physical and technology healthcare infrastructures for prescription drug distribution from manufacturer to patient through licensed pharmacies, today announced that it will report third quarter 2025 provide a business update and report financial results for the period ended September 30, 2025 on the morning of Thursday, November 20, 2025.

Ex-abbot of China's Shaolin Temple arrested for embezzlement

The former head of the Chinese temple known as the birthplace of kung fu has been arrested over suspicion of embezzlement, local authorities said Sunday.

Doha Tattoo Festival Announced as Ticket Sales Officially Open

DOHA, QA / ACCESS Newswire / November 16, 2025 / Under the patronage of His Excellency Sheikh Khalifa bin Hamad bin Khalifa Al Thani, Minister of Interior and Commander of the Internal Security Force (Lekhwiya), the first edition of the Doha International Music and Marching Festival (Doha Tattoo) will be held from 16 to 20 December 2025 at Katara Cultural Village.

Huge fire sparked by explosions near Argentine capital 'contained'

A large blaze ignited by powerful explosions at an industrial park near Argentina's capital has been contained, local authorities reported on Saturday.

Huge explosions rock industrial area near Argentina's capital

Powerful explosions tore through an industrial park near Argentina's capital on Friday, sparking a huge blaze and injuring more than 20 people.

Nine killed in accidental explosion at Indian Kashmir police station

Nine people were killed and 31 injured when confiscated explosives accidentally blew up at a police station in Indian-administered Kashmir, police said Saturday, just days after a car blast in Delhi killed a dozen people.

EU bows to pressure on loosening AI, privacy rules

The European Union is set next week to kickstart a rollback of landmark rules on artificial intelligence and data protection that face powerful pushback on both sides of the Atlantic.

Purdue Pharma to be dissolved as US judge says to approve bankruptcy

OxyContin maker Purdue Pharma, blamed for helping to fuel a deadly opioid crisis, said Friday that a US bankruptcy judge will sign off on a deal to settle thousands of lawsuits against the company, which will cease to exist.

New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television

Featured companies include Lionscrest Advisors, DataVault AI (NASDAQ:DVLT), Pudgy Penguins (PENGU)), Peer To Peer Network (OTC:PTOP), and Acurx Pharmaceuticals (NASDAQ:ACXP).

Trump demands probe into Epstein links to Bill Clinton

US President Donald Trump said Friday he wants the Justice Department and FBI to investigate links between the late alleged sex trafficker Jeffrey Epstein and former Democratic president Bill Clinton.

UN rights council orders probe of atrocities in Sudan's El-Fasher

The UN Human Rights Council on Friday ordered investigators to probe alleged atrocities in Sudan's El-Fasher and to seek to identify perpetrators so they can be brought to justice.

Thais navigate flooded homes and ancient temples by boat

For three months, Thai retiree Somkid Kijniyom has been sleeping in a small boat surviving on dry food handouts in the waist-high floodwaters that have filled his home.

Second brother of French anti-drugs activist murdered: prosecutor

A gunman on a motorbike has shot dead the 20-year-old youngest brother of a prominent anti-drug activist in the southern French city of Marseille in a possible warning over his campaigning, a prosecutor said on Friday.

BHP liable for 2015 Brazil mine disaster: UK court

A British court ruled Friday that Australian mining giant BHP is liable for one of Brazil's worst environmental disasters, potentially paving the way for billions of pounds in compensation.

What we know about deadly Delhi car blast

India has vowed to bring to justice the "perpetrators, their collaborators, and their sponsors" behind the deadliest explosion in the nation's capital for more than a decade.

Peru's interim president embraces the spotlight in 'war' on crime

Like a veritable action hero, Peru's interim president rolls up his sleeves to take part in nighttime raids on prisons and in the street, always making sure his bravado is captured on camera.

Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing

Pet-Food Revolution: Two New Global Surveys Reveal Growing Guardian Openness to Sustainable Diets for Dogs and Cats

LONDON, UK / ACCESS Newswire / November 14, 2025 / Two pioneering studies published in the journal Animals have explored in depth how dog and cat guardians perceive more sustainable pet food options. Led by Jenny L. Mace, Alexander Bauer, Andrew Knight and Billy Nicholles, the research sheds new light on the potential for alternative proteins and plant-based diets in the companion animal sector.

Wellgistics Health to Distribute Tollo Health GLP-1 Companion Muscle Loss Medical Food to Pharmacies & Physicians

Company to offer the first clinically validated dietary management of sarcopenia, now available for GLP-1 muscle loss, positioning Wellgistics to help 6,500+ independent pharmacy network (‘Pharmacy Network') and telehealth partners mitigate patient muscle loss in the GLP-1 drug market, estimated to grow to $150 billion by 2030Company to offer first SARS-CoV-2 related natural antiviral combo for Long COVID with addition of 3CL protease inhibitor supplement Tollovid® to Galectovid 1 & 3 inhibitor Medical Food Galectovid® distribution agreement to Pharmacy Network & physicians

Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates

Click here to registerCompany plans to file its Earnings Report on November 14, 2025 on Form 10-Q for the quarter ended September 30, 2025

NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th - NV-387 is Effective Against H3N2

SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting today, Friday, November 14th, at 11:25am ET at the Pharma Partnering Summit 2025 held at the Hilton Boston Logan Airport in Boston, MA.

TRNR Reports Record Third Quarter 2025 Results with 139% YoY Growth; Reiterates 2025 Pro Forma Revenue Guidance of $80M+ To Be Driven by Completion of Sportstech Acquisition

Quarterly Results Reflect First Full Quarter Including Wattbike (Acquisition Closed July 1)Company Reports Record Quarterly Revenue of $4.8 Million; Net Loss and Loss per Diluted Share of $5.2 Million and $3.11; Quarterly Adjusted EBITDA Loss of $2.9 million, Due to Low Inventory AvailabilitySportstech Acquisition Expected to Close in 2025 Based on Key Closing Milestone AchievementsReiterates 2025 Pro Forma Revenue Guidance of more than $80 million and Fourth Quarter Profitability Guidance

The Fort Worth Press - Boulevard (English)

Featured

Survivors pick up pieces in flood-hit Indonesia as more rain predicted

After 15 years, Dutch anti-blackface group declares victory

Last news